These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 2197718)

  • 1. [Combination insulin and sulfonylurea compounds in the therapy of type II diabetes mellitus].
    Diem P
    Schweiz Med Wochenschr; 1990 Jul; 120(27-28):987-8. PubMed ID: 2197718
    [No Abstract]   [Full Text] [Related]  

  • 2. Efficacy of insulin and sulfonylurea combination therapy in type II diabetes. A meta-analysis of the randomized placebo-controlled trials.
    Johnson JL; Wolf SL; Kabadi UM
    Arch Intern Med; 1996 Feb; 156(3):259-64. PubMed ID: 8572835
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Combination therapy insulin and sulfonylurea compounds. A critical analysis].
    Ratzmann KP; Berger M
    Z Arztl Fortbild (Jena); 1990; 84(21):1105-7. PubMed ID: 2281698
    [No Abstract]   [Full Text] [Related]  

  • 4. [Combined insulin-sulfonylurea in type II diabetes mellitus--an update].
    Ravina A; Minuchin O
    Harefuah; 1987 Nov; 113(10):285-7. PubMed ID: 3326798
    [No Abstract]   [Full Text] [Related]  

  • 5. [Combination therapy with sulfonylurea plus insulin in "secondary failure" of type 2 diabetes].
    Lotz N
    Ther Umsch; 1990 Jan; 47(1):49-54. PubMed ID: 2408182
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Combination sulfonylurea-insulin therapy in the treatment of noninsulin-dependent diabetes mellitus.
    Rosenblatt J
    Conn Med; 1991 Nov; 55(11):634-6. PubMed ID: 1790695
    [No Abstract]   [Full Text] [Related]  

  • 7. [Testing insulin and sulfonylurea sensitivity in type II diabetes mellitus].
    Holländer E
    Orv Hetil; 1984 Dec; 125(51):3103-6. PubMed ID: 6392996
    [No Abstract]   [Full Text] [Related]  

  • 8. Treatment of poorly regulated non-insulin-dependent diabetes mellitus with combination insulin-sulfonylurea.
    Allen BT; Feinglos MN; Lebovitz HE
    Arch Intern Med; 1985 Oct; 145(10):1900-3. PubMed ID: 3899039
    [No Abstract]   [Full Text] [Related]  

  • 9. [Combined insulin and sulfonylurea treatment in diabetes mellitus].
    Ravina A; Minuhin O
    Harefuah; 1986 Jan; 110(1):11-4. PubMed ID: 3514394
    [No Abstract]   [Full Text] [Related]  

  • 10. [Combination therapy with insulin and sulfonylurea].
    Takamatsu J
    Nihon Rinsho; 1997 Nov; 55 Suppl():255-60. PubMed ID: 9434477
    [No Abstract]   [Full Text] [Related]  

  • 11. [The importance of concurrent therapy with insulin and sulfonylurea derivatives in type II diabetes].
    Podrouzková B
    Vnitr Lek; 1994 May; 40(5):310-2. PubMed ID: 8023473
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Combination therapy with insulin and sulfonylurea].
    Bachmann W
    Dtsch Med Wochenschr; 1988 Apr; 113(16):652-4. PubMed ID: 3282863
    [No Abstract]   [Full Text] [Related]  

  • 13. Management of NIDDM.
    Kabadi UM
    J Fam Pract; 1992 Jan; 34(1):25. PubMed ID: 1728649
    [No Abstract]   [Full Text] [Related]  

  • 14. [Progress in insulin therapy of NIDDM].
    Kuzuya H
    Nihon Naika Gakkai Zasshi; 1991 Mar; 80(3):354-7. PubMed ID: 1856547
    [No Abstract]   [Full Text] [Related]  

  • 15. Combined chlorpropamide-insulin in the treatment of non-insulin-dependent diabetes mellitus with secondary failure of sulfonylurea therapy.
    Jiraratsatit J; Keoplung M; Chumsilp L; Chomchoengpatya P; Matayabun S
    J Med Assoc Thai; 1986 Dec; 69(12):627-34. PubMed ID: 3553408
    [No Abstract]   [Full Text] [Related]  

  • 16. [Insulin injection therapy of diabetes mellitus].
    Renner R
    Fortschr Med; 1990 Dec; 108(35):663-7. PubMed ID: 2276706
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Fear of the injection must not be an argument. Every second type 2 diabetic patient needs insulin].
    MMW Fortschr Med; 2002 Dec; 144(49):60. PubMed ID: 12577748
    [No Abstract]   [Full Text] [Related]  

  • 18. The treatment of noninsulin-dependent diabetes mellitus (NIDDM, type II DM) becomes more and more complex.
    Meinders AE; Lemkes HH
    Neth J Med; 1990 Feb; 36(1-2):39-42. PubMed ID: 2179751
    [No Abstract]   [Full Text] [Related]  

  • 19. [Delayed sulfonylurea resistance in non-insulin-dependent diabetes mellitus].
    Farkas K; Jermendy G; Somogyi A
    Orv Hetil; 1997 Nov; 138(48):3031-5. PubMed ID: 9441264
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Overview of current therapeutic options in type 2 diabetes. Rationale for combining oral agents with insulin therapy.
    Buse JB
    Diabetes Care; 1999 Apr; 22 Suppl 3():C65-70. PubMed ID: 10189565
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.